ICPerMed "Best Practice in Personalised Medicine" Recognition 2020

The International Consortium for Personalised Medicine (ICPerMed) has published the announcement of their "Best Practice in Personalised Medicine" Recognition 2020, which aims to recognise, encourage, promote and disseminate outstanding examples of best practices in personalised medicine. This third edition of this call is open to candidates worldwide, who have published scientific papers and/or developed best practice strategies in the field of personalised medicine between January 1st, 2018 and October 31st 2019. The deadline for proposal submission will be the 23rd January 2020.

The successful applicants (maximum number of three) will be invited to the ICPerMed Conference 2020 in Paris and will be given the opportunity to present their results during a plenary session. In addition, they will receive support for the dissemination of the best practice example by the ICPerMed Secretariat in the value of 500 €.

The applications have to refer to the third perspective outlined in the ICPerMed Vision Paper “Healthcare systems that enable personally-tailored and optimized health promotion, prevention, diagnosis, and treatment for the benefit of citizens and patients”. The best practice examples submitted can consist of one or several of the following:

These best practice examples can consist of one or several of the following:

  • Scientific paper focused on novel approaches for the implementation of personalised medicine;
  • Training programmes for health personnel, increasing the level of awareness on the potential of personalised medicine;
  • Examples for interdisciplinary or intersectoral groups of collaboration (governmental and non-governmental organisations, academic management, medical research, Health Care and SME), for the implementation of personalised medicine, including ELSI activities.

More information on the ICPerMed Recognition 2020: 



ICPerMed assembles over 40 European and international partners representing ministries, funding agencies and the European Commission. With the support of the ICPerMed Secretariat, the consortium works on coordinating and supporting research to develop approaches for personalised medicine. Thereby, the central aim of ICPerMed is to align and encourage joint efforts in personalised medicine research and implementation on a European and international level.

ANR is implicated in ICPerMed as well as in the ICPerMed Coordination and Support Action (ICPerMed Secretariat; CSA; 2016-2020) and ERA PerMed, the ERA Net on Personalised Medicine.